Also in 1973, he became one of the early faculty members in the newly organized MIT Center for Cancer capping a creative and industrious period of his career with nearly fifty research publications including the paradigm-shifting paper on reverse transcriptase. He is the president emeritus and Robert Andrews Millikan Professor of Biology at Caltech. This takes place through an enzyme known as "reverse transcriptase". [11][12][14], Baltimore extended this work and examined two RNA tumor viruses, Rauscher murine leukemia virus and Rous sarcoma virus. David Baltimore has filed for patents to protect the following inventions. [26], During this time, Baltimore's own research program thrived in the new Institute. [27] Their intention was to identify nuclear factors required for lg gene expression in B lymphocytes. [10][11] He also met his future wife, Alice Huang, who began working with Baltimore at Salk in 1967. The case was linked to Baltimore's name because of his scientific collaboration with and later his strong defense of Imanishi-Kari against accusations of fraud. Their results suggest that microRNA-146a protects HSCs during chronic inflammation, and that its lack may contribute to blood cancers and bone marrow failure. ", * PBS interview with Baltimore on AIDS, hepatitis, vaccines and science politics, https://en.wikipedia.org/w/index.php?title=David_Baltimore&oldid=989699637, Nobel laureates in Physiology or Medicine, California Institute of Technology faculty, Fellows of the American Academy of Arts and Sciences, Fellows of the American Association for the Advancement of Science, Massachusetts Institute of Technology School of Science faculty, Members of the European Molecular Biology Organization, Members of the French Academy of Sciences, Members of the Pontifical Academy of Sciences, Members of the United States National Academy of Sciences, Presidents of the California Institute of Technology, Members of the American Philosophical Society, Members of the National Academy of Medicine, Short description is different from Wikidata, Articles with unsourced statements from September 2008, Nobelprize template using Wikidata property P8024, Wikipedia articles with SELIBR identifiers, Wikipedia articles with SNAC-ID identifiers, Wikipedia articles with SUDOC identifiers, Wikipedia articles with WORLDCATID identifiers, Creative Commons Attribution-ShareAlike License. Baltimore served as the director of the Whitehead Institute until July 1, 1990, when he was appointed the sixth president of Rockefeller University in New York City. The case received extensive news coverage and a Congressional investigation. Initial reports of ribonucleic acid-dependent DNA polymerase activity: "The Discover Magazine Interview with David Baltimore" upon his retirement from the presidency of Caltech in 2006, This page was last edited on 20 November 2020, at 14:27. Gleevec has shown impressive results in treating chronic myelogenous leukemia and also promise in treating gastrointestinal stromal tumor (GIST).[32][33][34]. On May 13, 1997, Baltimore was appointed president of the California Institute of Technology (Caltech). They published these findings in back-to-back papers in the prestigious journal, Nature. Gladwell, Malcolm (July 14, 1992) "Prosecutors Halt Scientific Fraud Probe; Researcher Baltimore Claims Vindication, Plans to 'Unretract' Paper". After winning the Nobel Prize, Baltimore reorganized his laboratory, refocusing on immunology and virology, with immunoglobulin gene expression as a major area of interest. The infectious clone, DNA encoding the genome of a virus, is a standard tool used today in virology. In 1972, at the age of 34, Baltimore was awarded tenure as a professor of biology at MIT, a post that he held until 1997. American Association for the Advancement of Science, The Whitehead Institute for Biomedical Research, Foreign Member of the Royal Society (ForMemRS) in 1987, David Baltimore – Interviewed by Sara Lippincott; October – November 2009, "Viruses, Polymerases and Cancer:Nobel Lecture, December 12, 1975", "Alice Huang: Keeping Science and Life in Focus", "Destroying Dogma: the Discovery of Reverse Transcriptase", "Physiology or Medicine 1975 – Press Release", "Whitehead scientists enjoy genome sequence milestone", "Introduction of a mu immunoglobulin gene into the mouse germ line: specific expression in lymphoid cells and synthesis of functional antibody", "Pillars article: the V(D)J recombination activating gene, RAG-1.